Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Dales Natalie — Odyssey Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Dales Natalie

Dales Natalie

See Remarks at Odyssey Therapeutics, Inc. · on record since May 7, 2026

Insider trading activity of Dales Natalie

Transactions on record: 1; since May 11, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing May 11, 2026

Figures computed from official regulatory filings — methodology.

Companies where Dales Natalie has traded

Odyssey Therapeutics, Inc.1 tx · May 11, 2026

Track record of Dales Natalie

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Dales Natalie

Co-insiders of Dales Natalie

Chu ShelleyOdyssey Therapeutics, Inc.
COULTER JAMES GOdyssey Therapeutics, Inc.
Dimension Capital II, L.P.Odyssey Therapeutics, Inc.
George SimeonOdyssey Therapeutics, Inc.
Glick Gary DOdyssey Therapeutics, Inc.
Haas JasonOdyssey Therapeutics, Inc.
Hill PaulinaOdyssey Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

LEIDEN JEFFREY MOdyssey Therapeutics, Inc.

Li Nan (LN)Odyssey Therapeutics, Inc.

NG CAROLYNOdyssey Therapeutics, Inc.

Odegard ValerieOdyssey Therapeutics, Inc.

Opipari Anthony W.Odyssey Therapeutics, Inc.

Pavletic Aranicki KsenijaOdyssey Therapeutics, Inc.

Siegel JolieOdyssey Therapeutics, Inc.

SMITH IAN FOdyssey Therapeutics, Inc.

SR ONE CAPITAL MANAGEMENT, LLCOdyssey Therapeutics, Inc.

Tatsis OuraniaOdyssey Therapeutics, Inc.

Todd Collin MOdyssey Therapeutics, Inc.

TPG GP A, LLCOdyssey Therapeutics, Inc.

Walbert Timothy POdyssey Therapeutics, Inc.

WINKELRIED JONOdyssey Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Odyssey Therapeutics, Inc.	May 11, 2026	AwardD	79,773	0.00 USD	$0	SEC